BMO Capital Raises Amgen Price Target to $442 From $415
BMO Capital adjusted its price target on Amgen; the wire body notes the stock has an average rating of hold.
Related stories
Nomad Foods Q3 Adjusted Earnings Fall as Revenue Rises
Nomad Foods maintained its 2026 adjusted earnings guidance.
M impact | EQUITY | Nov 04, 2026, 02:01 PM UTC
Scotiabank to announce fourth-quarter 2026 results
Scotiabank says it will announce its fourth-quarter results on Wednesday, Dec. The announcement date is incomplete in the source.
M impact | EQUITY | Nov 04, 2026, 02:00 PM UTC
Voyager Technologies Wins $35M NASA HUNCH Management Contract
Voyager Technologies was awarded a five-year contract to manage NASA’s HUNCH program, extending a role it has held since 2021.
M impact | EQUITY | Nov 04, 2026, 02:00 PM UTC
NHPC Q2 consolidated revenue from operations at 44.83 billion rupees
M impact | EQUITY | Nov 04, 2026, 01:59 PM UTC
MGE Energy Reports Q3 2026 Operating Revenue of $190.4 Million
M impact | EQUITY | Nov 04, 2026, 01:59 PM UTC
US Equity Futures Rise Pre-Bell as Traders Assess Midterm Election Results
US equity futures rose before the bell as traders assessed the implications of a Democratic win in the US midterm elections.
M impact | EQUITY | Nov 04, 2026, 01:59 PM UTC